Riskpilot← Back to searchSign inGet full accessKARMSUND PROTEIN AS
ASActiveOrg 921007906Real estate activities with own property and development of building projects · NACE 6810Est. 20180 employees
Revenue 2022
NOK 262K
EBITDA margin
77.9%
+504% vs 2021
Equity ratio
22.9%
Financial strength
Net profit 2022
NOK -263K
+28% vs 2021
| Revenue | NOK 262K | — |
| EBITDA | NOK 204K | +504% |
| Net profit | NOK -263K | +28% |
| Total assets | NOK 15,3M | +0% |
| Equity | NOK 3,5M | -7% |
| Employees | 0 | — |
Legal name
KARMSUND PROTEIN AS
Org number
921007906
Legal form
Aksjeselskap
NACE code
6810 · Real estate activities with own property and development of building projects
Founded
15. juni 2018
Share capital
NOK 5 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Company purpose
Kjøp, utvikling og salg av eiendommer, utleie av eiendom, samt hva hermed står i forbindelse, herunder å delta i andre foretak med tilsvarende virksomhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 262 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −7 | −0 | −31 | −50 | 204 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −7 | −0 | −31 | −50 | 204 |
| Net financials | −24 | −460 | −358 | −317 | −467 |
| Profit before tax | −31 | −461 | −389 | −367 | −263 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −31 | −461 | −389 | −367 | −263 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 16 972 | 16 480 | 15 719 | 15 222 | 15 255 |
| Equity | 4 969 | 4 509 | 4 120 | 3 753 | 3 489 |
| Long-term debt | 12 000 | 11 969 | 11 597 | 11 457 | 11 762 |
| Short-term debt | 2 | 3 | 2 | 13 | 3 |
| Total debt | 12 002 | 11 972 | 11 599 | 11 470 | 11 766 |
EBITDA margin
77.9%
This company
15.8%
Market median
+393% vs market
20182022
Equity ratio
22.9%
This company
38.2%
Market median
-40% vs market
20182022
Return on equity
-7.6%
This company
18.4%
Market median
-141% vs market
20182022
Net profit margin
-100.7%
This company
8.1%
Market median
-1343% vs market
20182022
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20182022
Debt / equity
3.37×
This company
0.62×
Market median
-444% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-05-31 – 2018-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 51% | 51% | 2022 | |
| Company | 49% | 49% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Thore As
KARMSUND PROTEIN AS Board members of KARMSUND PROTEIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arnt-Ove Blytt-Tøsdal Kolås | Board of Directors | 0 companies |
| Egil Magne Haugstad | Chairman | 0 companies |
| Aleksander Vedø | Board of Directors | 0 companies |
| Arve Henning Hystad | Board of Directors | 0 companies |